Of particular interest were the inhibition of nephrin, podocin, and Z0-1, expression of which is inhibited in the streptozotocin model of Type 1 diabetes and whose inhibition is plausibly contributory to impaired function in diabetic nephropathy [25] (Figure 3A). This evidence concerns the gene NPHS2 and diabetic kidney disease.